Summary Information:
Alimera Sciences Inc. Common Stock
NASDAQ:ALIM


email
[email protected]
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Alimera Sciences Inc. Common Stock
Exchange: NASDAQ
Symbol: ALIM
SEC CIK: 0001267602
Phone: 678-990-5740
6120 WINDWARD PARKWAY
STE 290
ALPHARETTA GA 30005
CEO: C. Daniel Myers
Price when page updated: 3.45 Date: 2023-11-30
Company Website:
www.alimerasciences.com

_Description: Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations.

IPO YEAR:
2010
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
180838101.00
Beta:
1.598620405647969
52 Week High:
12.25
52 Week Low:
3.94
52 Week Change:
0.2302483069977428
Short Interest:

Short Date:

Shares Outstanding:
6938154
Dividend Rate:
0
Dividend Yield:
0.50%
ExDividend Date:

Latest EPS:

Latest EPS Date:
2 Nov 2022
Float:
0
return on Equity:
21.70%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$135.485M
ttmEPS:
0
Revenue:
$1.434B
Gross Profit:

Cash:

Debt:

Institution Percent:
32.80%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
3.00%
Return on Assets:
-7.60%
Return on Capital:

Profit Margin:
-8.30%
Price to Sales:
0.86
Price To Book:
-
Short Ratio:
1.34
PE Ratio:
0
Employees:
135
1Y Guesstimate
12.670:1.0:1




__The following are links to various summary and news pages for
__Alimera Sciences Inc. Common Stock [ ALIM ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30